Penn Vet maps progression of inherited blinding disease in dogs

CURRENT BRIEF VERSION: Penn Vet researchers have published what they describe as the first detailed long-term map of how progressive rod-cone degeneration, or PRCD, advances in dogs, a common inherited cause of canine blindness that parallels retinitis pigmentosa in people. In the new Experimental Eye Research study, the team used multimodal retinal imaging to show a consistent pattern of outer retinal thinning that starts in the periphery and moves inward toward the center over time. Penn Vet says the findings are already being used in its Ryan Veterinary Hospital Retinal Health Clinic to support earlier detection, more accurate monitoring, and clearer prognostic counseling for pet parents. (vet.upenn.edu)

Why it matters: For veterinary professionals, the study offers a more practical disease-progression framework for a condition that can be difficult to stage early, especially before central vision is obviously affected. That matters because PRCD is one of the most common inherited forms of progressive retinal atrophy in dogs and affects more than 75 breeds, while also serving as a translational model for human inherited retinal disease. A clearer map of where degeneration begins and how it spreads could improve screening, follow-up intervals, client communication, and enrollment strategies for future therapeutic studies. More broadly, it adds to a growing body of veterinary ophthalmology work aimed at defining disease course earlier and more precisely, including recent JAVMA data showing that central corneal degeneration syndrome in older dogs can progress from nonulcerative central or paraxial stromal thinning to near-perforation or perforation over time, sometimes requiring surgical repair.

What to watch: Watch for this disease-staging approach to show up more formally in referral ophthalmology workflows and in the design of future canine and human retinal therapy trials. Separately, clinicians should keep an eye on emerging guidance around other progressive ocular diseases in older dogs, including CCDS, where longer-term follow-up may help identify when monitoring is no longer enough and surgery is warranted.